Skip to content

OsteoCure Therapeutics, Inc

Plug and Play · OsteoCure Therapeutics is advancing an adenosine platform with systemic treatments for reversing osteoporosis and local therapies for accelerating fracture and mitigating pain.

Same space

Also from Plug and Play

All of Plug and Play

Programs

Programs OsteoCure Therapeutics, Inc went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About OsteoCure Therapeutics, Inc

"OsteoCure Therapeutics, Inc. is a groundbreaking lifetech and medtech company focused on revolutionizing bone health through their innovative adenosine platform. By developing two lead programs, OCTA1 and OCTA2, OsteoCure offers localized therapies for fracture and fusion repair, as well as systemic treatments for osteoporosis. Their adenosine platform, utilizing a naturally occurring molecule, delivers tailored solutions for acute injury repair and chronic bone loss, outperforming current standards. With a strong foundation in Duke University research and validation through preclinical studies, OsteoCure is positioned to make a significant impact in orthopedic repair and osteoporosis treatment markets. Led by a team of experts, including co-founders Hunter Newman, PhD, and Shyni Varghese, PhD, OsteoCure is poised for early clinical advancements and strategic partnerships in the industry."

Category
Other
Location
United States
Checked
4h ago

OsteoCure Therapeutics, Inc: questions

Which accelerators did OsteoCure Therapeutics, Inc go through?

OsteoCure Therapeutics, Inc is listed by Plug and Play.

Where is OsteoCure Therapeutics, Inc based?

OsteoCure Therapeutics, Inc lists United States as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.